These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 25450618)
1. Thermodynamic parameters for binding of some halogenated inhibitors of human protein kinase CK2. Winiewska M; Makowska M; Maj P; Wielechowska M; Bretner M; Poznański J; Shugar D Biochem Biophys Res Commun; 2015 Jan; 456(1):282-7. PubMed ID: 25450618 [TBL] [Abstract][Full Text] [Related]
2. Thermodynamics parameters for binding of halogenated benzotriazole inhibitors of human protein kinase CK2α. Winiewska M; Kucińska K; Makowska M; Poznański J; Shugar D Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1708-17. PubMed ID: 25891901 [TBL] [Abstract][Full Text] [Related]
3. Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: evaluation of their effects on cells and different molecular forms of human CK2. Zien P; Duncan JS; Skierski J; Bretner M; Litchfield DW; Shugar D Biochim Biophys Acta; 2005 Dec; 1754(1-2):271-80. PubMed ID: 16203192 [TBL] [Abstract][Full Text] [Related]
4. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT. Leung KK; Shilton BH Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648 [TBL] [Abstract][Full Text] [Related]
5. Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α. Wąsik R; Wińska P; Poznański J; Shugar D PLoS One; 2012; 7(11):e48898. PubMed ID: 23155426 [TBL] [Abstract][Full Text] [Related]
6. A competition between hydrophobic and electrostatic interactions in protein-ligand systems. Binding of heterogeneously halogenated benzotriazoles by the catalytic subunit of human protein kinase CK2. Kasperowicz S; Marzec E; Maciejewska AM; Trzybiński D; Bretner M; Woźniak K; Poznański J; Mieczkowska K IUBMB Life; 2020 Jun; 72(6):1211-1219. PubMed ID: 32162783 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and physico-chemical properties in aqueous medium of all possible isomeric bromo analogues of benzo-1H-triazole, potential inhibitors of protein kinases. Wąsik R; Wińska P; Poznański J; Shugar D J Phys Chem B; 2012 Jun; 116(24):7259-68. PubMed ID: 22632480 [TBL] [Abstract][Full Text] [Related]
8. Relative role of halogen bonds and hydrophobic interactions in inhibition of human protein kinase CK2α by tetrabromobenzotriazole and some C5-substituted analogues. Wasik R; Łebska M; Felczak K; Poznański J; Shugar D J Phys Chem B; 2010 Aug; 114(32):10601-11. PubMed ID: 20734498 [TBL] [Abstract][Full Text] [Related]
9. Halogen Atoms in the Protein-Ligand System. Structural and Thermodynamic Studies of the Binding of Bromobenzotriazoles by the Catalytic Subunit of Human Protein Kinase CK2. Czapinska H; Winiewska-Szajewska M; Szymaniec-Rutkowska A; Piasecka A; Bochtler M; Poznański J J Phys Chem B; 2021 Mar; 125(10):2491-2503. PubMed ID: 33689348 [TBL] [Abstract][Full Text] [Related]
10. The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules. Battistutta R; Mazzorana M; Cendron L; Bortolato A; Sarno S; Kazimierczuk Z; Zanotti G; Moro S; Pinna LA Chembiochem; 2007 Oct; 8(15):1804-9. PubMed ID: 17768728 [TBL] [Abstract][Full Text] [Related]
11. New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole. Bretner M; Najda-Bernatowicz A; Łebska M; Muszyńska G; Kilanowicz A; Sapota A Mol Cell Biochem; 2008 Sep; 316(1-2):87-9. PubMed ID: 18548199 [TBL] [Abstract][Full Text] [Related]
12. Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources. Zień P; Bretner M; Zastapiło K; Szyszka R; Shugar D Biochem Biophys Res Commun; 2003 Jun; 306(1):129-33. PubMed ID: 12788077 [TBL] [Abstract][Full Text] [Related]
13. ITC-derived binding affinity may be biased due to titrant (nano)-aggregation. Binding of halogenated benzotriazoles to the catalytic domain of human protein kinase CK2. Winiewska M; Bugajska E; Poznański J PLoS One; 2017; 12(3):e0173260. PubMed ID: 28273138 [TBL] [Abstract][Full Text] [Related]
14. Exploring the binding of inhibitors derived from tetrabromobenzimidazole to the CK2 protein using a QM/MM-PB/SA approach. Retegan M; Milet A; Jamet H J Chem Inf Model; 2009 Apr; 49(4):963-71. PubMed ID: 19354274 [TBL] [Abstract][Full Text] [Related]
15. Interaction between CK2α and CK2β, the subunits of protein kinase CK2: thermodynamic contributions of key residues on the CK2α surface. Raaf J; Bischoff N; Klopffleisch K; Brunstein E; Olsen BB; Vilk G; Litchfield DW; Issinger OG; Niefind K Biochemistry; 2011 Feb; 50(4):512-22. PubMed ID: 21142136 [TBL] [Abstract][Full Text] [Related]
16. A subnanomolar fluorescent probe for protein kinase CK2 interaction studies. Enkvist E; Viht K; Bischoff N; Vahter J; Saaver S; Raidaru G; Issinger OG; Niefind K; Uri A Org Biomol Chem; 2012 Nov; 10(43):8645-53. PubMed ID: 23032938 [TBL] [Abstract][Full Text] [Related]
17. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole. Battistutta R; Mazzorana M; Sarno S; Kazimierczuk Z; Zanotti G; Pinna LA Chem Biol; 2005 Nov; 12(11):1211-9. PubMed ID: 16298300 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of Novel Halogenated Heterocycles Based on Winiewska-Szajewska M; Maciejewska AM; Speina E; Poznański J; Paprocki D Molecules; 2021 May; 26(11):. PubMed ID: 34070615 [TBL] [Abstract][Full Text] [Related]
19. Semiempirical quantum mechanical method PM6-DH2X describes the geometry and energetics of CK2-inhibitor complexes involving halogen bonds well, while the empirical potential fails. Dobes P; Rezác J; Fanfrlík J; Otyepka M; Hobza P J Phys Chem B; 2011 Jul; 115(26):8581-9. PubMed ID: 21648479 [TBL] [Abstract][Full Text] [Related]
20. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole. Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]